1. Home
  2. TWIN vs LCTX Comparison

TWIN vs LCTX Comparison

Compare TWIN & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

N/A

Current Price

$23.04

Market Cap

320.9M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.08

Market Cap

301.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWIN
LCTX
Founded
1918
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.9M
301.7M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
TWIN
LCTX
Price
$23.04
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
87.2K
906.7K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$340,738,000.00
$14,556,000.00
Revenue This Year
$10.79
$109.40
Revenue Next Year
$8.43
N/A
P/E Ratio
$13.31
N/A
Revenue Growth
15.45
53.24
52 Week Low
$12.00
$1.00
52 Week High
$25.50
$2.09

Technical Indicators

Market Signals
Indicator
TWIN
LCTX
Relative Strength Index (RSI) 49.03 43.16
Support Level $21.57 $1.00
Resistance Level $24.28 $1.18
Average True Range (ATR) 1.23 0.05
MACD -0.15 0.00
Stochastic Oscillator 37.31 25.00

Price Performance

Historical Comparison
TWIN
LCTX

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: